Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.61 USD | -1.86% | +1.22% | +34.06% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.06% | 2.38B | |
+11.31% | 87.43B | |
+7.52% | 79.69B | |
-12.20% | 56.79B | |
+23.30% | 47.14B | |
+32.46% | 46.62B | |
-26.51% | 45.5B | |
+81.90% | 42.31B | |
-6.42% | 25.81B | |
+21.21% | 22.27B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Transcript : Cellebrite DI Ltd. - Analyst/Investor Day